Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Chamilos, G., Lewis, R. E., & Kontoyiannis, D. P. Clinical Infectious Diseases, 47(4):503 – 509, 2008. Cited by: 629; All Open Access, Bronze Open Access
Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis [link]Paper  doi  bibtex   
@ARTICLE{Chamilos2008503,
	author = {Chamilos, Georgios and Lewis, Russell E. and Kontoyiannis, Dimitrios P.},
	title = {Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis},
	year = {2008},
	journal = {Clinical Infectious Diseases},
	volume = {47},
	number = {4},
	pages = {503 – 509},
	doi = {10.1086/590004},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-48749096676&doi=10.1086%2f590004&partnerID=40&md5=389e7a2694e755f8522ab7f94bcbd143},
	type = {Article},
	publication_stage = {Final},
	source = {Scopus},
	note = {Cited by: 629; All Open Access, Bronze Open Access}
}

Downloads: 0